novel investigational antibiotic

Basilea Pharmaceutica Has Submitted a Marketing Authorization Application
Dec 5, 2012
Basilea Pharmaceutica has submitted a marketing authorization application (MAA) under the European decentralized procedure for its novel investigational antibiotic, ceftobiprole, to treat pneumonia in hospitals. The submission of the ...

Tags: MRSA, ceftobiprole, novel investigational antibiotic